Publication | Open Access

Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

Metabolic SyndromeType 1UrologyDiabetes ManagementMedicineDiabetesClinical TrialsDiabetic Kidney DiseaseDiabetes MellitusFine-one TrialChronic Kidney DiseaseHealth Sciences